Vemed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
- Paid Up Capital ₹ 0.60 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.90 Cr
- Revenue Growth %
- Net Worth -3173.72%
- Total Assets 166.28%
About Vemed Pharmaceuticals
Vemed Pharmaceuticals Private Limited (VPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 October 2020 (Four years and four months 6 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹19.90 Cr.
Debabrata Saha, Manav Saha, Milin Thakkar, and Two other members serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290GJ2020PTC117049
-
Company No.
117049
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Oct 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Vemed Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nainesh Patel
|
Director | 05-Oct-2020 | Current |
|
Debabrata Saha
|
Alternate Director | 24-Dec-2021 | Current |
|
Manav Saha
|
Director | 05-Oct-2020 | Current |
|
Milin Thakkar
|
Director | 05-Oct-2020 | Current |
|
Krishna Saha
|
Director | 05-Oct-2020 | Current |
Financial Performance of Vemed Pharmaceuticals.
Vemed Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 3173.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vemed Pharmaceuticals?
Unlock access to Vemed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Starlink Seva FoundationDebabrata Saha and Manav Saha are mutual person
-
Starlinks Resources Private LimitedDebabrata Saha is a mutual person
-
Starlinks Pharma Private LimitedDebabrata Saha and Manav Saha are mutual person
Charges (Loans)
₹199.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 19.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2023 | Others | ₹9.95 Cr | Open |
| 21 Jun 2023 | Others | ₹9.95 Cr | Open |
How Many Employees Work at Vemed Pharmaceuticals?
Vemed Pharmaceuticals has a workforce of 11 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vemed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vemed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.